HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angiotensin II induces oxidative stress in prostate cancer.

Abstract
Angiotensin II has been shown to be a cytokine especially acting as a growth factor. A local renin-angiotensin system has been identified in the prostate gland, and the physiologic function of angiotensin II seems to be similar in prostate cancer, as we previously reported. In the present study, we explored the biological role of angiotensin II in oxidative stress of prostate cancer cells. Activated Akt was determined, and the expression of oxidative stress-related proteins (p47phox, manganese superoxide dismutase 2, glutathione peroxidase) was examined by Western blotting in LNCaP cells, which were stimulated with angiotensin II and/or an angiotensin II receptor type 1 blocker, candesartan. To examine DNA damage induced by angiotensin II, 8-hydroxy-2'-deoxyguanosine was determined, and Western blots were analyzed to detect checkpoint proteins including p53, Chk2, and cdc2. Immunocytochemical studies of inducible nitric oxide synthase and superoxide anion radical (O(2)(-)) were done in LNCaP cells stimulated with angiotensin II. The phosphorylation of Akt was induced by angiotensin II treatment and inhibited by candesartan, as well as by LY294002, an inhibitor of phosphoinositide 3-kinase. Oxidative stress-related proteins were up-regulated by angiotensin II and inhibited by pretreatment with candesartan or catalase. The level of 8-hydroxy-2'-deoxyguanosine was increased by angiotensin II and conversely decreased by candesartan. Immunocytochemical studies showed that angiotensin II enhanced an inflammatory marker, inducible nitric oxide synthase, and the production of O(2)(-) radical. The hypothesis that angiotensin II has the potential to induce oxidative stress, which may be implicated in carcinogenesis of the prostate gland through long-term exposure to chronic inflammation is proposed.
AuthorsHiroji Uemura, Hitoshi Ishiguro, Yukari Ishiguro, Kouji Hoshino, Satoru Takahashi, Yoshinobu Kubota
JournalMolecular cancer research : MCR (Mol Cancer Res) Vol. 6 Issue 2 Pg. 250-8 (Feb 2008) ISSN: 1541-7786 [Print] United States
PMID18314486 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiotensin II Type 1 Receptor Blockers
  • Cell Cycle Proteins
  • Receptor, Angiotensin, Type 1
  • Superoxides
  • Angiotensin II
  • 8-Hydroxy-2'-Deoxyguanosine
  • Nitric Oxide Synthase Type II
  • Proto-Oncogene Proteins c-akt
  • Deoxyguanosine
Topics
  • 8-Hydroxy-2'-Deoxyguanosine
  • Angiotensin II (pharmacology)
  • Angiotensin II Type 1 Receptor Blockers (pharmacology)
  • Cell Cycle Proteins (metabolism)
  • Cell Line, Tumor
  • DNA Damage
  • Deoxyguanosine (analogs & derivatives, metabolism)
  • Humans
  • Immunohistochemistry
  • Male
  • Microscopy, Confocal
  • Models, Biological
  • Nitric Oxide Synthase Type II (metabolism)
  • Oxidative Stress (drug effects)
  • Phosphorylation (drug effects)
  • Prostatic Neoplasms (enzymology, metabolism, pathology)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Receptor, Angiotensin, Type 1 (metabolism)
  • Superoxides (metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: